Mezzion Pharma Co 140410
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₩27,450.00
- Day Range
- ₩27,450.00–29,800.00
- 52-Week Range
- —–—
- Bid/Ask
- ₩29,300.00 / ₩29,350.00
- Market Cap
- ₩875.35 Bil
- Volume/Avg
- 117,930 / 97,642
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 40.42
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Mezzion Pharma Co is a South Korea based drug manufacturer company. It develops and manufactures pharmaceutical products for erectile dysfunction and benign prostatic hyperplasia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Small Core
- Total Number of Employees
- 17
- Website
- http://www.mezzion.co.kr
Comparables
Valuation
|
Metric
|
140410
|
271980
|
068760
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 32.19 | 172.20 |
Price/Book Value | 19.33 | 1.23 | 7.73 |
Price/Sales | 40.42 | 0.30 | 7.16 |
Price/Cash Flow | — | 21.14 | 79.15 |
Price/Earnings
140410
271980
068760
Financial Strength
|
Metric
|
140410
|
271980
|
068760
|
|---|---|---|---|
Quick Ratio | 2.03 | 0.69 | 0.98 |
Current Ratio | 2.65 | 1.11 | 1.50 |
Interest Coverage | −29.56 | −5.42 | 2.70 |
Quick Ratio
140410
271980
068760
Profitability
|
Metric
|
140410
|
271980
|
068760
|
|---|---|---|---|
Return on Assets (Normalized) | −13.89% | −6.08% | 2.54% |
Return on Equity (Normalized) | −23.04% | −17.86% | 4.37% |
Return on Invested Capital (Normalized) | −20.98% | −10.71% | 3.89% |
Return on Assets
140410
271980
068760
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Gdmqxjyq | Smvd | $798.8 Bil | |||
| Johnson & Johnson
JNJ
| Fqkqysjd | Dcw | $385.9 Bil | |||
| AbbVie Inc
ABBV
| Cxfykrvt | Dtzz | $343.2 Bil | |||
| Merck & Co Inc
MRK
| Kmhnmhgc | Cgbh | $278.2 Bil | |||
| Roche Holding AG ADR
RHHBY
| Jnxsvqwp | Ymb | $244.4 Bil | |||
| AstraZeneca PLC ADR
AZN
| Pxxggwpty | Npgm | $238.9 Bil | |||
| Novartis AG ADR
NVS
| Cpcmhbf | Mpqb | $232.2 Bil | |||
| Amgen Inc
AMGN
| Wbqwqysldy | Dmxml | $171.8 Bil | |||
| Pfizer Inc
PFE
| Bbbjlmn | Ztxmt | $162.0 Bil | |||
| Sanofi SA ADR
SNY
| Wgrgmdskz | Drl | $140.7 Bil |
United States